Aditxt (ADTX) announced that its board of directors has authorized management to explore taking its subsidiary, Pearsanta, public via a proposed initial public offering in 2025. Pearsanta has advanced its development and operational capabilities, particularly in early cancer detection, by leveraging its proprietary Mitomic Technology platform.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio